Metamizole (dipyrone) is a pyrazolone derivative that belongs to the group of nonacid nonopioids. It is considered a potent analgesic and antipyretic with favourable gastrointestinal tolerability. Metamizole was formerly marketed in the US as Dimethone tablets and injection, Protemp oral liquid, and other drug products, and was withdrawn due to its associati...
Metamizole is banned in several countries, where it was previously used as a powerful analgesic and fever reducer. In countries where it is still available, metamizole is indicated for acute severe pain after injuries or surgeries, colic, tumor pain, and acute or severe pain symptoms, as well as high fever if other treatments are unsuccessful.
Ángel Becerra, Las Palmas De Gran Canaria, Las Palmas, Spain
Anesthesiology Jessa hospital, Hasselt, Belgium
Leszek Giec Upper-Silesia Medical Center of the Medical University of Silesia in Katowice, Katowice, Poland
Santa Casa de Misericórdia de Votuporanga, Votuporanga, São Paulo, Brazil
Hospital Universitário São Francisco na Providência de Deus, Bragança Paulista, São Paulo, Brazil
Associação Hospital de Caridade Ijuí - Núcleo de Ensino e Pesquisa, Ijuí, Rio Grande Do Sul, Brazil
University Hospital, Basel, Switzerland
Jessa Hospital, Hasselt, Limburg, Belgium
Clinical Trial Unit, University Hospital Basel, Basel, BS, Switzerland
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.